Biogen Inc.
Biogen Inc. (USA) is linked to 1 FDA-registered manufacturing site. 7 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Biogen Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/biogen-inc
Overview
Biogen Inc. is a global biotechnology company specializing in the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases. Biogen is committed to advancing pioneering science to address some of the most challenging diseases affecting humanity.
Core services & business areas
Therapeutic areas
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Biogen Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
7 FDA enforcement records linked to this company.
- 4832017-04-06
Late submission of annual safety reports
- 4832017-04-06
Late submission of 15-day report
- 4832015-06-26
Procedures not in writing, fully followed
- 4832015-06-26
Procedures for non-sterile drug products
- 4832014-07-03
Late submission of 15-day report
- 4832014-07-03
Non-applicant reports directly to FDA
- 4832009-09-30
Late submission of 15-day report
Is this Biogen Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.